Background.Poor quality of drug prescribing in older persons is often associated with increased drug-related adverse events, hospitalization, and mortality. The present study describes a set of prescribing quality indicators developed by the Geriatrics Working Group of the Italian Medicines Agency (AIFA) and estimates their prevalence in the entire elderly (≥65 years) population in Italy.Methods.We performed a cross-sectional study using 2011 data from the OsMed (Osservatorio dei Medicinali) database, which comprises all prescribed drugs that are reimbursed by the Italian National Healthcare System. Yearly prevalence of drug prescribing quality indicators in the Italian older population (n = 12,301,537) was determined.Results.Overall, 13 quality indicators addressing polypharmacy, adherence to treatment of chronic diseases, prescribing cascade, undertreatment, drug-drug interactions, and drugs to be avoided were identified. Polypharmacy was common, with more than 1.3 million individuals taking greater than or equal to 10 drugs (11.3% of the study population). The prevalence of low adherence and undertreatment was also elevated and increased with advancing age, with highest prevalence occurring in individuals aged 85 years and older. Prevalence was less than 3% for quality indicators assessing the prescribing cascade, drug-drug interactions, and drugs to be avoided.Conclusions.These results confirm the high frequency of suboptimal drug prescribing in older adults, using a database that covers the whole Italian population. In general, this descriptive study may help in prioritizing strategies aimed at improving the quality of prescribing in elderly population. © The Author 2013.

High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA) / Onder, G.; Bonassi, S.; Abbatecola, A. M.; Folino-Gallo, P.; Lapi, F.; Marchionni, N.; Pani, L.; Pecorelli, S.; Sancarlo, D.; Scuteri, A.; Trifiro, G.; Vitale, C.; Zuccaro, S. M.; Bernabei, R.; Fini, M.. - In: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. - ISSN 1079-5006. - 69:4(2014), pp. 430-437.

High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA)

Pani L.;
2014

Abstract

Background.Poor quality of drug prescribing in older persons is often associated with increased drug-related adverse events, hospitalization, and mortality. The present study describes a set of prescribing quality indicators developed by the Geriatrics Working Group of the Italian Medicines Agency (AIFA) and estimates their prevalence in the entire elderly (≥65 years) population in Italy.Methods.We performed a cross-sectional study using 2011 data from the OsMed (Osservatorio dei Medicinali) database, which comprises all prescribed drugs that are reimbursed by the Italian National Healthcare System. Yearly prevalence of drug prescribing quality indicators in the Italian older population (n = 12,301,537) was determined.Results.Overall, 13 quality indicators addressing polypharmacy, adherence to treatment of chronic diseases, prescribing cascade, undertreatment, drug-drug interactions, and drugs to be avoided were identified. Polypharmacy was common, with more than 1.3 million individuals taking greater than or equal to 10 drugs (11.3% of the study population). The prevalence of low adherence and undertreatment was also elevated and increased with advancing age, with highest prevalence occurring in individuals aged 85 years and older. Prevalence was less than 3% for quality indicators assessing the prescribing cascade, drug-drug interactions, and drugs to be avoided.Conclusions.These results confirm the high frequency of suboptimal drug prescribing in older adults, using a database that covers the whole Italian population. In general, this descriptive study may help in prioritizing strategies aimed at improving the quality of prescribing in elderly population. © The Author 2013.
69
4
430
437
High prevalence of poor quality drug prescribing in older individuals: A nationwide report from the Italian Medicines Agency (AIFA) / Onder, G.; Bonassi, S.; Abbatecola, A. M.; Folino-Gallo, P.; Lapi, F.; Marchionni, N.; Pani, L.; Pecorelli, S.; Sancarlo, D.; Scuteri, A.; Trifiro, G.; Vitale, C.; Zuccaro, S. M.; Bernabei, R.; Fini, M.. - In: JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES. - ISSN 1079-5006. - 69:4(2014), pp. 430-437.
Onder, G.; Bonassi, S.; Abbatecola, A. M.; Folino-Gallo, P.; Lapi, F.; Marchionni, N.; Pani, L.; Pecorelli, S.; Sancarlo, D.; Scuteri, A.; Trifiro, G.; Vitale, C.; Zuccaro, S. M.; Bernabei, R.; Fini, M.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11380/1211980
Citazioni
  • ???jsp.display-item.citation.pmc??? 31
  • Scopus 88
  • ???jsp.display-item.citation.isi??? 78
social impact